Smithers, a bioanalytical contract research organization (CRO), understands the unique bioanalytical and regulatory challenges inherent to bi-specific antibody development and has performed bioanalytical analysis for  bi- and multi-specific antibodies at various stages of pre- and clinical development. Services include discovery bioassay, ADA assay, PK, Nab and ultra-sensitive biomarker services.

Latest Resources

See all resources